alexa Xiaobin Xu | Regeneron Pharmaceuticals
ISSN: 0974-276X

Journal of Proteomics & Bioinformatics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Xiaobin Xu

Xiaobin Xu Xiaobin Xu
Scientist, Analytical Chemistry
Regeneron Pharmaceuticals, Inc.
USA
 
 
Biography

Dr. Xiaobin Xu is a Scientist in Regeneron Pharmaceuticals, developing analytical methods for characterization of monoclonal antibody drugs. He has received his PhD from Boston University, where he confused on mass spectrometry-based proteomics. His research has included developing MS based analytical methods for the characterization of therapeutic proteins, HDX-MS, cross-linking MS for protein-protein interaction studies, and quantitative proteomics. He is serving as expert reviewers for many peer-viewed mass spectrometry journals.

Research Interest

Research  interest includes developing MS based analytical methods for the characterization of therapeutic proteins, HDX-MS, cross-linking MS for protein-protein interaction studies, and quantitative proteomics.

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords